Pyxis Oncology

Contributing Author

Recent Articles by Pyxis Oncology

Feb-03	Pyxis Oncology Announces Interim CEO Appointment and Leadership Transition to Support Strategic Focus and Program Continuity PYXS GlobeNewswire
Dec-18	Pyxis Oncology Announces Positive Preliminary Phase 1 Data for Micvotabart Pelidotin (MICVO) in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma PYXS -48.66% GlobeNewswire
Nov-03	Pyxis Oncology to Participate in Upcoming Investor Conferences PYXS +7.02% GlobeNewswire
Nov-03	Pyxis Oncology Provides Business Update and Reports Third Quarter 2025 Financial Results PYXS +7.02% GlobeNewswire
Oct-13	Pyxis Oncology to Present Translational Data and Key Biology Findings Elucidating the Mechanism of Action of MICVO at Upcoming Medical Meetings PYXS -6.76% PYXS -6.38% GlobeNewswire
Oct-09	Pyxis Oncology Appoints Alex Kane as Senior Vice President, Investor Relations & Capital Markets PYXS +31.62% GlobeNewswire
Sep-30	Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PYXS GlobeNewswire
Aug-21	Pyxis Oncology to Participate in September Investor and Industry Conferences PYXS +13.79% GlobeNewswire
Aug-14	Pyxis Oncology Reports Second Quarter 2025 Financial Results and Provides Business Update PYXS +8.85% PYXS +5.61% GlobeNewswire
Jun-30	Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PYXS GlobeNewswire
May-15	Pyxis Oncology Reports First Quarter 2025 Financial Results and Provides Business Update PYXS GlobeNewswire
May-14	Pyxis Oncology to Participate in Two Upcoming Investor Conferences PYXS -10.08% GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved.